Are late complications of Parkinson’s disease really late? YES


Published in: Cesk Slov Neurol N 2019; 115(3): 0
Category: Controversions


Sources

1. Postuma RB, Berg D, Stern M et al. MDS clinical dia­g­nostic criteria for Parkinson’s disease. Mov Disord 2015; 30(12): 1591–1601. doi: 10.1002/mds.26424.

2. Henner K. Speclní neurologie. Praha: Státní zdravotnické nakladatelství 1953.

3. Lopez CI, Ruiz PJ, Del Pozo SV et al. Motor complications in Parkinsonś disease: ten year follow up study. Mov Disord 2010; 25(16): 2735–2739. doi: 10.1002/mds.23219.

4. Warren Olanow C, Kieburtz K, Rascol O et al. Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinsonś disease. Mov Disord 2013; 28(8): 1064–1071. doi: 10.1002/mds.25364.

5. Szatmari S, Illigens BM, Siepmann T et al. Neuropsychiatric symptoms in untreated Parkinsonś disease. Neuropsychiatr Dis Treat 2017; 13: 815–826. doi: 10.2147/NDT.S130997.

6. Weintraub D, Tröster AI, Marras C et al. Initial cognitive changes in Parkinsonś disease. Mov Disord 2018; 33(4): 511–519. doi: 10.1002/mds.27330.

7. Rajput AH. Levodopa prolongs life expectancy and is non-toxic to substantia nigra. Parkinsonism Relat Disord 2001; 8(2): 95–100.

8. Postuma RB, Berg D. Advances in markers of prodromal Parkinsonś disease. Nat Rev Neurol 2016; 12(11): 622–634. doi: 10.1038/nrneurol.2016.152.

Labels
Paediatric neurology Neurosurgery Neurology

Article was published in

Czech and Slovak Neurology and Neurosurgery

Issue 3

2019 Issue 3

Most read in this issue

This topic is also in:


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account